Online citations, reference lists, and bibliographies.
← Back to Search

Activity And Safety Of Erlotinib As Second- And Third-line Treatment In Elderly Patients With Advanced Non-small Cell Lung Cancer: A Phase II Trial

David Rossi, Donatella Dennetta, Marcello Ugolini, Vincenzo Catalano, Paolo Alessandroni, Paolo Giordani, Anna Maria Baldelli, Virginia Casadei, Francesco Graziano, S. Luzi Fedeli

Save to my Library
Download PDF
Analyze on Scholarcy
Share